2017
DOI: 10.1161/jaha.117.006027
|View full text |Cite
|
Sign up to set email alerts
|

Trends in Racial/Ethnic Disparities in Cardiovascular Health Among US Adults From 1999–2012

Abstract: BackgroundIn the United States, there are persistent racial and ethnic disparities in cardiovascular disease morbidity and mortality. National efforts have focused on reducing these disparities; however, little is known about the long‐term trends in racial/ethnic disparities in cardiovascular health (CVH).Methods and ResultsWe included 11 285 adults aged ≥20 years from the National Health and Nutrition Examination Surveys survey cycles 1999/2000 through 2011/2012. CVH includes 7 health factors and behaviors—di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
111
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 156 publications
(115 citation statements)
references
References 25 publications
4
111
0
Order By: Relevance
“…Then, we conducted a multivariable logistic regression analysis of whether sociodemographic characteristics were associated with statin use among those with a history of ASCVD using pooled data from 2014 through 2016, the 3 years that follow the publication of the 2013 ACC/AHA guidelines. [15][16][17][18] Statin use for secondary prevention was defined as 1 or more prescriptions filled within the calendar year among our population of interest, those aged 40 and older with a history of diagnosed ASCVD. 20 We identified generic and brand-name statin fills from all prescription drug fills reported using Cerner Multum drug codes and/or medication names.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Then, we conducted a multivariable logistic regression analysis of whether sociodemographic characteristics were associated with statin use among those with a history of ASCVD using pooled data from 2014 through 2016, the 3 years that follow the publication of the 2013 ACC/AHA guidelines. [15][16][17][18] Statin use for secondary prevention was defined as 1 or more prescriptions filled within the calendar year among our population of interest, those aged 40 and older with a history of diagnosed ASCVD. 20 We identified generic and brand-name statin fills from all prescription drug fills reported using Cerner Multum drug codes and/or medication names.…”
Section: Methodsmentioning
confidence: 99%
“…We also assessed whether individual sociodemographic characteristics are associated with statin use for individuals with a history of ASCVD. Given known disparities in ASCVD treatment among women and racial/ethnic minorities, [15][16][17][18] we wanted to understand whether these disparities persisted using the most current data available. We also capture those who are on Medicaid (only or dually eligible for Medicare) or uninsured, populations that are often missed in claims-based analyses that typically include only those with Medicare and/or private coverage.…”
mentioning
confidence: 99%
“…Yet nearly 40% of CVD is attributed to modifiable social determinants of health including poor diet, exercise, and smoking which worsen endothelial function and arterial compliance [ 5 ]. These trends are further complicated by health disparities including racial and sexual [ 6 ]. Aside from the ethical toll, health disparities every year account for over 1 in 10 health expenditure dollars or $1.24 trillion every three years [ 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, racial/ethnic differences in overall cardiovascular health may be more prominent for women than for men. 3 Estimates suggest that %44% of the decline in ASCVD death rates is attributable to improvements in CVD-related lifestyle and behavior factors, including improvements in rates of smoking, physical inactivity, and control of systolic blood pressure and total cholesterol. 4 However, declines in the prevalence of these risk factors are being offset by the increasing prevalence of obesity and diabetes mellitus.…”
mentioning
confidence: 99%